ACTRN12605000213640招募中1 期
A Phase I clinical trial of infusion of donor-derived HLA-A*0201-restricted CMV pp65 peptide-specific CTL to reconstitute CMV-specific immunity after allogeneic haematopoietic stem cell transplantation.
Department of Haematology, Westmead Hospital0 个研究点目标入组 12 人开始时间: 2005年8月25日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Prevention
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- ot stated 至 ot stated（—）
- 性别
- All
入选标准
- •HLA-A*0201 pos and CMV seropositive donor, 5/6 or 6/6 sib match or 6/6/MUD, GVHD < grade II at the time of infusion, >day 28 post allogeneic HSCT, no recent anti-lymphocyte globulin.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
1 期
A phase I clinical trial on the use of autograft mesenchymal stem cells for treatment of diabetic chronic kidney diseaseDiabetic Nephropathy.Diabetic nephropathyIRCT138804091267N19rology and Nephrology Research Center ( UNRC), Shahid Beheshti University, M.C.( SBMU), Tehran, I.10
进行中（未招募）
不适用
A phase I-II study: infusion of donor lymphocytes transduced with the suicide gene HSV TK, after transplantation of allogeneic T-depleted stem cells from a haploidentical donor in patients with haematological malignancies - TK007Hematological malignancies at high risk of relapse based on disease progression or presence of negative prognostic factor, who have received a HCTfrom donor HLA mismatched (haploidentical) for 2 or 3 loci.EUCTR2005-003587-34-GRMolMed70
尚未招募
1 期
Mesenchymal Stem Cell Therapy For Covid 19CTRI/2020/08/027043eurogen Brain and Spine Institute
进行中（未招募）
1 期
Treatment with daratumumab injections in moderate to severe ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 20.1Level: LLTClassification code 10028414Term: Myalgic encephalomyelitisSystem Organ Class: 100000004862EUCTR2022-000281-18-NOHaukeland University Hospital, Dept. of Oncology and Medical Physics10
进行中（未招募）
1 期
Daratumumab in ME/CFSMyalgic Encephalomyelitis/Chronic Fatigue SyndromeMedDRA version: 26.1Level: LLTClassification code: 10028414Term: Myalgic encephalomyelitis Class: 10021881CTIS2024-512500-19-00Helse Bergen HF10